Header Logo

Huy G Vuong

InstitutionUniversity of Oklahoma Health Sciences Center
AddressHHDC 4000
1000 N Lincoln Blvd
Oklahoma City OK 73104
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vuong HG, Dunn IF. Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival. World Neurosurg. 2022 Mar 24. PMID: 35339711.
    2. Vuong HG, Le HT, Dunn IF. The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas. Cancer. 2022 May 15; 128(10):1907-1912. PMID: 35195909.
      Citations:    Fields:    
    3. Vuong HG, Le MK, Hassell L, Kondo T, Kakudo K. The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes. Head Neck. 2022 04; 44(4):926-932. PMID: 35076146.
      Citations:    Fields:    
    4. Vuong HG, Ngo TNM, Dunn IF. Incidence, Prognostic Factors, and Survival Trend in Pineal Gland Tumors: A Population-Based Analysis. Front Oncol. 2021; 11:780173. PMID: 34869031.
    5. Vuong HG, Le HT, Ngo TNM, Fung KM, Battiste JD, McNall-Knapp R, Dunn IF. H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients. J Neurooncol. 2021 Dec; 155(3):225-234. PMID: 34796414.
      Citations:    Fields:    Translation:Humans
    6. Bui Q, Ngo TNM, Mazur J, Pham V, Palmer C, Truong BQ, Chung ES, Vuong HG, Truong VT. Long-term outcomes of primary cardiac malignant tumors: Difference between African American and Caucasian population. Cancer Med. 2021 12; 10(24):8838-8845. PMID: 34761875.
      Citations: 1     Fields:    
    7. Vuong HG, Nguyen DD, El-Rassi E, Ngo TNM, Dunn IF. Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study. World Neurosurg. 2022 01; 157:e245-e253. PMID: 34628034.
      Citations:    Fields:    Translation:HumansPHPublic Health
    8. Ngo TNM, Le TTB, Le T, Bychkov A, Oishi N, Jung CK, Hassell L, Kakudo K, Vuong HG. Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data. Endocr Pathol. 2021 Dec; 32(4):489-500. PMID: 34559383.
      Citations: 1     Fields:    
    9. Rana C, Vuong HG, Nguyen TQ, Nguyen HC, Jung CK, Kakudo K, Bychkov A. The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the Reclassification. Thyroid. 2021 10; 31(10):1502-1513. PMID: 34060946.
      Citations: 3     Fields:    
    10. Vuong HG, Ngo TNM, Dunn IF. Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab084. PMID: 34345819.
    11. Vuong HG, Nguyen TPX, Ngo HTT, Hassell L, Kakudo K. Malignant thyroid teratoma: an integrated analysis of case series/case reports. Endocr Relat Cancer. 2021 06 17; 28(7):495-503. PMID: 34010145.
      Citations:    Fields:    
    12. Vuong HG, Ngo TNM, Dunn IF. Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis. Cancer Med. 2021 07; 10(13):4415-4423. PMID: 34085407.
      Citations: 3     Fields:    Translation:Humans
    13. Vuong HG, Jung CK, Kakudo K, Bychkov A. Response to Cherella et al. re: "The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis". Thyroid. 2021 09; 31(9):1442-1444. PMID: 33858233.
      Citations:    Fields:    Translation:Humans
    14. Vuong HG, Suzuki A, Na HY, Tuyen PV, Khuy DM, Nguyen HC, Jitpasutham T, Abelardo A, Amano T, Park SY, Jung CK, Hirokawa M, Katoh R, Kakudo K, Bychkov A. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Pediatric Population. Am J Clin Pathol. 2021 04 26; 155(5):680-689. PMID: 33269383.
      Citations: 3     Fields:    Translation:Humans
    15. Vuong HG, Ngo TNM, Dunn IF. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis. J Neurooncol. 2021 May; 153(1):15-22. PMID: 33770323.
      Citations:    Fields:    Translation:Humans
    16. Nguyen PN, Tran NTB, Nguyen TPX, Ngo TNM, Lai DV, Deel CD, Hassell LA, Vuong HG. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):431-438. PMID: 33849798.
      Citations:    Fields:    Translation:HumansCells
    17. Vuong HG, Chung DGB, Ngo LM, Bui TQ, Hassell L, Jung CK, Kakudo K, Bychkov A. The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis. Thyroid. 2021 08; 31(8):1203-1211. PMID: 33504264.
      Citations: 2     Fields:    Translation:Humans
    18. Vuong HG, Nguyen TPX, Pham N, Dunn IF. Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis. Pituitary. 2021 Jun; 24(3):429-437. PMID: 33205233.
      Citations: 2     Fields:    Translation:Humans
    19. Oishi N, Vuong HG, Mochizuki K, Kondo T. Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations. Endocr Pathol. 2020 Dec; 31(4):359-366. PMID: 33058026.
      Citations: 3     Fields:    Translation:HumansCells
    20. Nguyen TPX, Truong VT, Kakudo K, Vuong HG. The diversities in thyroid cytopathology practices among Asian countries using the Bethesda system for reporting thyroid cytopathology. Gland Surg. 2020 Oct; 9(5):1735-1746. PMID: 33224851.
    21. Odate T, Oishi N, Vuong HG, Mochizuki K, Kondo T. Genetic differences in follicular thyroid carcinoma between Asian and Western countries: a systematic review. Gland Surg. 2020 Oct; 9(5):1813-1826. PMID: 33224857.
    22. Vuong HG, Nguyen TQ, Nguyen HC, Nguyen PT, Ho ATN, Hassell L. Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis. Target Oncol. 2020 10; 15(5):589-598. PMID: 32865687.
      Citations: 3     Fields:    Translation:Humans
    23. Vuong HG, Nguyen TQ, Ngo TNM, Nguyen HC, Fung KM, Dunn IF. The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis. BMC Cancer. 2020 Sep 21; 20(1):897. PMID: 32957941.
      Citations: 5     Fields:    Translation:HumansCells
    24. Ngo HTT, Nguyen TPX, Vu TH, Jung CK, Hassell L, Kakudo K, Vuong HG. Impact of Molecular Testing on the Management of Indeterminate Thyroid Nodules Among Western and Asian Countries: a Systematic Review and Meta-analysis. Endocr Pathol. 2021 Jun; 32(2):269-279. PMID: 32767256.
      Citations: 1     Fields:    Translation:Humans
    25. Vuong HG, Nguyen TPX, Hassell LA, Jung CK. Diagnostic performances of the Afirma Gene Sequencing Classifier in comparison with the Gene Expression Classifier: A meta-analysis. Cancer Cytopathol. 2021 03; 129(3):182-189. PMID: 32726885.
      Citations: 2     Fields:    Translation:Humans
    26. Vuong HG, Ngo HTT, Bychkov A, Jung CK, Vu TH, Lu KB, Kakudo K, Kondo T. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis. Cancer Cytopathol. 2020 04; 128(4):238-249. PMID: 31883438.
      Citations: 19     Fields:    Translation:Humans
    27. Odate T, Vuong HG, Mochizuki K, Oishi N, Kondo T. Assessment of peritoneal elastic laminal invasion improves survival stratification of pT3 and pT4a colorectal cancer: a meta-analysis. J Clin Pathol. 2019 Nov; 72(11):736-740. PMID: 31471468.
      Citations:    Fields:    Translation:Humans
    28. Vuong HG, Ho ATN, Tran TTK, Capdevila J, Benekli M, Nakazawa T, Katoh R, Kondo T. Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis. Head Neck. 2019 08; 41(8):2823-2829. PMID: 31162772.
      Citations: 1     Fields:    Translation:Humans
      Citations: 9     Fields:    Translation:Humans
    30. Vuong HG, Long NP, Anh NH, Nghi TD, Hieu MV, Hung LP, Nakazawa T, Katoh R, Kondo T. Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis. Endocr Connect. 2018 Dec 01; 7(12):R286-R293. PMID: 30352403.
    31. Vuong HG, Tran TTK, Ngo HTT, Pham TQ, Nakazawa T, Fung KM, Hassell L, Katoh R, Kondo T. Prognostic significance of genetic biomarkers in isocitrate dehydrogenase-wild-type lower-grade glioma: the need to further stratify this tumor entity - a meta-analysis. Eur J Neurol. 2019 03; 26(3):379-387. PMID: 30298540.
      Citations: 5     Fields:    Translation:Humans
    32. Farber-Katz S, Hsuan V, Wu S, Landrith T, Vuong H, Xu D, Li B, Hoo J, Lam S, Nashed S, Toppmeyer D, Gray P, Haynes G, Lu HM, Elliott A, Tippin Davis B, Karam R. Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay. Front Oncol. 2018; 8:286. PMID: 30101128.
    33. Vuong HG, Ho ATN, Altibi AMA, Nakazawa T, Katoh R, Kondo T. Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer - A systematic review and meta-analysis. Lung Cancer. 2018 09; 123:76-82. PMID: 30089599.
      Citations: 20     Fields:    Translation:HumansAnimals
    34. Nakazawa T, Kondo T, Vuong HG, Odate T, Kawai M, Tahara I, Kasai K, Inoue T, Oishi N, Mochizuki K, Ito K, Katoh R. High expression of CD10 in anaplastic thyroid carcinomas. Histopathology. 2018 Sep; 73(3):492-499. PMID: 29791034.
      Citations: 4     Fields:    Translation:Humans
    35. Gray PN, Tsai P, Chen D, Wu S, Hoo J, Mu W, Li B, Vuong H, Lu HM, Batth N, Willett S, Uyeda L, Shah S, Gau CL, Umali M, Espenschied C, Janicek M, Brown S, Margileth D, Dobrea L, Wagman L, Rana H, Hall MJ, Ross T, Terdiman J, Cullinane C, Ries S, Totten E, Elliott AM. TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome. Oncotarget. 2018 Apr 17; 9(29):20304-20322. PMID: 29755653.
      Citations: 9     Fields:    
    36. Vuong HG, Odate T, Ngo HTT, Pham TQ, Tran TTK, Mochizuki K, Nakazawa T, Katoh R, Kondo T. Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis. Endocr Relat Cancer. 2018 06; 25(6):633-641. PMID: 29615431.
      Citations: 10     Fields:    Translation:Humans
    37. Vuong HG, Duong UNP, Pham TQ, Tran HM, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R, Kondo T. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis. World J Surg. 2018 04; 42(4):1005-1017. PMID: 28913696.
      Citations: 16     Fields:    Translation:Humans
    38. Vuong HG, Odate T, Duong UNP, Mochizuki K, Nakazawa T, Katoh R, Kondo T. Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis. Head Neck. 2018 07; 40(7):1588-1597. PMID: 29509280.
      Citations: 9     Fields:    Translation:Humans
    39. Vuong HG, Altibi AMA, Duong UNP, Ngo HTT, Pham TQ, Chan AK, Park CK, Fung KM, Hassell L. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data. Crit Rev Oncol Hematol. 2017 Dec; 120:1-9. PMID: 29198322.
      Citations: 17     Fields:    Translation:HumansCells
    40. Vuong HG, Altibi AM, Duong UN, Ngo HT, Pham TQ, Tran HM, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R, Kondo T. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis. Tumour Biol. 2017 Oct; 39(10):1010428317713913. PMID: 29037127.
      Citations: 14     Fields:    Translation:HumansCells
    41. Vuong HG, Kondo T, Oishi N, Nakazawa T, Mochizuki K, Miyauchi A, Hirokawa M, Katoh R. Paediatric follicular thyroid carcinoma - indolent cancer with low prevalence of RAS mutations and absence of PAX8-PPARG fusion in a Japanese population. Histopathology. 2017 Nov; 71(5):760-768. PMID: 28621837.
      Citations: 8     Fields:    Translation:Humans
    42. Vuong HG, Altibi AMA, Duong UNP, Hassell L. Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis. Clin Endocrinol (Oxf). 2017 Nov; 87(5):411-417. PMID: 28666074.
      Citations: 35     Fields:    Translation:HumansCells
    43. Hirokawa M, Miyauchi A, Kihara M, Kudo T, Hashimoto Y, Suzuki S, Daa T, Vuong HG, Mitsutake N. Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex. Endocr J. 2017 Sep 30; 64(9):843-850. PMID: 28680002.
      Citations: 1     Fields:    Translation:Humans
    44. Vuong HG, Kondo T, Duong UNP, Pham TQ, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R. Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol. 2017 Aug; 177(2):207-216. PMID: 28566444.
      Citations: 5     Fields:    Translation:Humans
    45. Vuong HG, Altibi AMA, Duong UNP, Ngo HTT, Pham TQ, Fung KM, Hassell L. BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis. Mol Neurobiol. 2018 May; 55(5):3718-3724. PMID: 28534272.
      Citations: 17     Fields:    Translation:Humans
    46. Vuong HG, Kondo T, Pham TQ, Oishi N, Mochizuki K, Nakazawa T, Hassell L, Katoh R. Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol. 2017 Apr; 176(4):433-441. PMID: 28183787.
      Citations: 9     Fields:    Translation:Humans
    47. Vuong HG, Duong UN, Altibi AM, Ngo HT, Pham TQ, Tran HM, Gandolfi G, Hassell L. A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocr Connect. 2017 Apr; 6(3):R8-R17. PMID: 28219937.
    48. Vuong HG, Altibi AM, Abdelhamid AH, Ngoc PU, Quan VD, Tantawi MY, Elfil M, Vu TL, Elgebaly A, Oishi N, Nakazawa T, Hirayama K, Katoh R, Huy NT, Kondo T. The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review. Oncotarget. 2017 Feb 07; 8(6):10637-10649. PMID: 27793009.
      Citations: 27     Fields:    Translation:HumansCells
    49. Gray PN, Vuong H, Tsai P, Lu HM, Mu W, Hsuan V, Hoo J, Shah S, Uyeda L, Fox S, Patel H, Janicek M, Brown S, Dobrea L, Wagman L, Plimack E, Mehra R, Golemis EA, Bilusic M, Zibelman M, Elliott A. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy. Oncotarget. 2016 Oct 18; 7(42):68206-68228. PMID: 27626691.
      Citations: 6     Fields:    Translation:Humans
    50. Vuong HG, Kondo T, Oishi N, Nakazawa T, Mochizuki K, Inoue T, Tahara I, Kasai K, Hirokawa M, Tran TM, Katoh R. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries. Cancer Med. 2016 08; 5(8):1883-9. PMID: 27264674.
      Citations: 15     Fields:    Translation:Humans
    51. Oishi N, Kondo T, Vuong HG, Nakazawa T, Mochizuki K, Kasai K, Inoue T, Tahara I, Hirokawa M, Miyauchi A, Katoh R. Immunohistochemical detection of NRAS(Q61R) protein in follicular-patterned thyroid tumors. Hum Pathol. 2016 07; 53:51-7. PMID: 26980032.
      Citations: 4     Fields:    Translation:HumansCells
    52. Vuong HG, Kondo T, Tran TM, Oishi N, Nakazawa T, Mochizuki K, Inoue T, Kasai K, Tahara I, Jieying W, Katoh R. Spindle cell oncocytoma of adenohypophysis: Report of a case and immunohistochemical review of literature. Pathol Res Pract. 2016 Mar; 212(3):222-5. PMID: 26839157.
      Citations: 9     Fields:    Translation:Humans
    53. Meador CB, Jin H, de Stanchina E, Nebhan CA, Pirazzoli V, Wang L, Lu P, Vuong H, Hutchinson KE, Jia P, Chen X, Eisenberg R, Ladanyi M, Politi K, Zhao Z, Lovly CM, Cross DA, Pao W. Optimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancer. Mol Cancer Ther. 2015 Feb; 14(2):542-52. PMID: 25477325.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    54. Vuong H, Patterson T, Shapiro P, Kalvakolanu DV, Wu R, Ma WY, Dong Z, Kleeberger SR, Reddy SP. Phorbol ester-induced expression of airway squamous cell differentiation marker, SPRR1B, is regulated by protein kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 signal transduction pathway. J Biol Chem. 2000 Oct 13; 275(41):32250-9. PMID: 10918063.
      Citations: 7     Fields:    Translation:HumansCells
    Same Department Expand Description